Discussion on Cooperation Strategies with the Delegation from the Singapore Chamber of Commerce in Korea

The National Institute for Korean Medicine Development held a meeting with the delegation from the Singapore Chamber of Commerce in Korea (hereafter referred to as the delegation) on April 7, to discuss strategies for expanding the Korean medicine industry overseas and potential avenues for cooperation.


The meeting was attended by Justin Yong, Chairman of the Singapore Chamber of Commerce in Korea, Emilia Zainal, Co-Chair of the Joint Committee, and Jasmine Lee, Director. Representing the Institute were Lee Hwa-dong, Director of the Industry Promotion Division; Park Tae-soon, Head of the Industry Growth Support Center; Kang Byung-man, Head of the Herbal Medicine Production Center; and Kim Jeong-ok, Head of the Herbal Material Development Center.

Provided by the National Institute for Korean Medicine Development

Provided by the National Institute for Korean Medicine Development

View original image

The delegation expressed strong interest in Korean medicine. Chairman Justin Yong stated, "Demand for Korean medicine continues to grow steadily in Singapore. Personally, I am highly satisfied with its therapeutic effects, and I want to gain a deeper understanding of the industry as a whole."


The discussion focused on the 'standardization' of Korean medicine.


It was explained that, in order to be recognized as a pharmaceutical product in Singapore, clear ingredient and quality standards are required, making the establishment of a regulatory framework crucial for market entry.


On this point, Director Lee Hwa-dong stated, "The National Institute for Korean Medicine Development has already established 61 standardized clinical practice guidelines for Korean medicine, and herbal preparations are also managed for safety and quality through product approvals by the Ministry of Food and Drug Safety."


Chairman Justin Yong emphasized, "To open a Korean medicine clinic in Singapore, the ingredients of herbal medicines must be clearly disclosed. Indicating which materials are included in herbal prescriptions would greatly help to build consumer trust."


In response, the National Institute for Korean Medicine Development explained that it is currently promoting an information service that enables consumers to directly verify the raw ingredients and preparation details of herbal medicines prescribed at Korean medical institutions via QR codes.


Positive expectations for market potential were also shared.


Jasmine Lee, Director, said, "As in other countries, there is growing interest in health and wellness in Singapore—extending beyond K-beauty—which has led to heightened interest in Korean medicine. If Korean medicine enters the market in earnest, it will be sufficiently competitive, and successful establishment in Singapore could help expand into the Southeast Asian market."


Both sides agreed on the need to establish sustainable channels for cooperation, such as future delegation exchanges and expanded collaboration between companies. The Singaporean delegation stated, "We hope that the Institute will play an intermediary role to facilitate ongoing exchanges and information sharing among Korean medicine companies."



Meanwhile, the National Institute for Korean Medicine Development is pursuing a range of globalization initiatives for Korean medicine, including export support for companies, overseas expansion of medical institutions, attracting foreign patients, and ODA projects.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing